Investor Roche Holding Ltd
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Roche Holding Ltd . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2019-03-20 13D/A SENS / Senseonics Holdings, Inc. 29,319,010 29,319,010
2018-07-31 13D/A FMI / Foundation Medicine, Inc. 21,019,111 101
2018-06-19 13D/A FMI / Foundation Medicine, Inc. 22,040,026 21,019,111
2018-01-02 13D 451731103 / Ignyta, Inc. 4,324,235
2017-06-09 13D SENS / Senseonics Holdings, Inc. 8,042,414 29,319,010
2017-02-07 13G AVXS / AveXis, Inc. 1,543,843
2017-02-07 13G SENS / Senseonics Holdings, Inc. 8,042,414
2015-04-23 13D/A FMI / Foundation Medicine, Inc. 22,190,984 22,040,026
2015-04-09 13D/A FMI / Foundation Medicine, Inc. 22,190,984
2015-01-21 13D FMI / Foundation Medicine, Inc. 9,309,525
2013-01-15 13G/A ARWR / Arrowhead Pharmaceuticals, Inc. 0